Wilson Carole L, Schmidt Amy P, Pirilä Emma, Valore Erika V, Ferri Nicola, Sorsa Timo, Ganz Tomas, Parks William C
Department of Pathology and Center for Lung Biology, University of Washington, Seattle, Washington 98104, USA.
J Biol Chem. 2009 Mar 27;284(13):8301-11. doi: 10.1074/jbc.M809744200. Epub 2009 Jan 30.
Proteolytic processing of defensins is a critical mode of posttranslational regulation of peptide activity. Because mouse alpha-defensin precursors are cleaved and activated by matrix metalloproteinase-7 (MMP-7), we determined if additional defensin molecules, namely human neutrophil defensin pro-HNP-1 and beta-defensins, are targets for MMP-7. We found that MMP-7 cleaves within the pro-domain of the HNP-1 precursor, a reaction that does not generate the mature peptide but produces a 59-amino acid intermediate. This intermediate, which retains the carboxyl-terminal end of the pro-domain, had antimicrobial activity, indicating that the residues important for masking defensin activity reside in the amino terminus of this domain. Mature HNP-1 was resistant to processing by MMP-7 unless the peptide was reduced and alkylated, demonstrating that only the pro-domain of alpha-defensins is normally accessible for cleavage by this enzyme. From the 47-residue HBD-1 precursor, MMP-7 catalyzed removal of 6 amino acids from the amino terminus. Neither a 39-residue intermediate form of HBD-1 nor the mature 36-residue form of HBD-1 was cleaved by MMP-7. In addition, both pro-HBD-2, with its shorter amino-terminal extension, and pro-HBD-3 were resistant to MMP-7. However, human and mouse beta-defensin precursors that lack disulfide bonding contain a cryptic MMP-7-sensitive site within the mature peptide moiety. These findings support and extend accumulating evidence that the native three-dimensional structure of both alpha- and beta-defensins protects the mature peptides against proteolytic processing by MMP-7. We also conclude that sites for MMP-7 cleavage are more common at the amino termini of alpha-defensin rather than beta-defensin precursors, and that catalysis at these sites in alpha-defensin pro-domains results in acquisition of defensin activity.
防御素的蛋白水解加工是肽活性翻译后调控的关键模式。由于小鼠α-防御素前体可被基质金属蛋白酶-7(MMP-7)切割并激活,我们确定了其他防御素分子,即人中性粒细胞防御素前体HNP-1和β-防御素,是否为MMP-7的作用靶点。我们发现MMP-7在HNP-1前体的前结构域内进行切割,该反应不会产生成熟肽,而是产生一个59个氨基酸的中间体。这个保留了前结构域羧基末端的中间体具有抗菌活性,表明掩盖防御素活性的重要残基位于该结构域的氨基末端。成熟的HNP-1对MMP-7的加工具有抗性,除非该肽被还原和烷基化,这表明通常只有α-防御素 的前结构域可被该酶切割。对于47个氨基酸残基的HBD-1前体,MMP-7催化从氨基末端去除6个氨基酸。HBD-1的39个氨基酸残基的中间形式和成熟的36个氨基酸残基形式均未被MMP-7切割。此外,氨基末端延伸较短的前体HBD-2和前体HBD-3均对MMP-7具有抗性。然而,缺乏二硫键的人和小鼠β-防御素前体在成熟肽部分内含有一个隐蔽的MMP-7敏感位点。这些发现支持并扩展了越来越多的证据,即α-和β-防御素的天然三维结构可保护成熟肽免受MMP-7的蛋白水解加工。我们还得出结论,MMP-7切割位点在α-防御素而不是β-防御素前体的氨基末端更为常见,并且α-防御素前结构域中这些位点的催化作用导致防御素活性的获得。